| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 01/05/2011 | CN101934051A Six-depression soup |
| 01/05/2011 | CN101934048A Traditional Chinese medicine compound preparation for treating respiratory disease and preparation method thereof |
| 01/05/2011 | CN101934042A Chinese herbal medicament for treating bronchiectasis |
| 01/05/2011 | CN101934041A Chinese medicinal herb for treating pleurisy |
| 01/05/2011 | CN101934027A Oral Chinese traditional medicine for treating chronic pharyngolaryngitis |
| 01/05/2011 | CN101934026A Chinese medicinal composition for treating cough and asthma and preparation method thereof |
| 01/05/2011 | CN101934009A Preparation method for processed arisaema tubers |
| 01/05/2011 | CN101934006A Chinese herbal medicine for treating bronchial asthma |
| 01/05/2011 | CN101933998A Chinese medicine for treating bird flu |
| 01/05/2011 | CN101933996A Chinese medicinal composition having effects of clearing heat, relieving fire and eliminating toxins and preparation and detection methods thereof |
| 01/05/2011 | CN101933994A Botanical for preventing and curing asthma of chickens |
| 01/05/2011 | CN101933989A Chinese herbal medicament for treating acute bronchitis |
| 01/05/2011 | CN101933983A Traditional Chinese medicinal composition for treating allergic rhinitis, preparation thereof and preparation method thereof |
| 01/05/2011 | CN101933971A Oral liquid of honeysuckle flower and baical skullcap root and preparation method thereof |
| 01/05/2011 | CN101933964A Application of conyza blinii total saponins for preparing anti-neoplastic drug |
| 01/05/2011 | CN101933961A Sanicula lamelligera hance sesquiterpene extract for treating influenza |
| 01/05/2011 | CN101933927A Composition containing enrofloxacin hexahydrate and application thereof to preparation of medicaments for treating or preventing diseases of domestic animals |
| 01/05/2011 | CN101933926A Indolylmaleimde derivatives as PKC inhibitors |
| 01/05/2011 | CN101933653A Officinal health-care solid electronic aerosolization liquid and preparation method thereof |
| 01/05/2011 | CN101507767B Traditional Chinese medicine composite for treating horse pneumonia |
| 01/05/2011 | CN101502524B Application of acetyl-fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 01/05/2011 | CN101502523B Application of benzoyl fluorobenzene salicylamide compound in preparing anti-tumor medicament |
| 01/05/2011 | CN101491621B Traditional Chinese medicine composition for treating sinusitis and preparation method thereof |
| 01/05/2011 | CN101297965B Applications of thymic peptide beta4 in preparing medicament for preventing and treating bronchial asthma |
| 01/04/2011 | US7863446 Heterocycles |
| 01/04/2011 | US7863445 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 01/04/2011 | US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders |
| 01/04/2011 | US7863241 Lung surfactant polypeptide, and at least one inhibitor of a mediator of tissue destruction; for example protease inhibitors; treating inflammatory lung conditions such as asthma, chronic obstructive pulmonary disease |
| 01/04/2011 | US7863047 Intracorporeal medicaments for photodynamic treatment of disease |
| 01/04/2011 | CA2558191C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 01/04/2011 | CA2521271C Quinoline-2-one-derivatives for the treatment of airways diseases |
| 01/04/2011 | CA2493995C Macrolide compounds endowed with antiinflammatory activity |
| 01/04/2011 | CA2491871C Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 01/04/2011 | CA2491027C Novel flavone c-glycoside derivatives and compositions containing the derivatives |
| 01/04/2011 | CA2479638C Hfa-suspension formulations of crystalline tiotropium bromide anhydrate |
| 01/04/2011 | CA2468517C Thioether substituted imidazoquinolines |
| 01/04/2011 | CA2462953C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/04/2011 | CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same |
| 01/04/2011 | CA2458533C Imidazole derivates as anti-inflammatory agents |
| 01/04/2011 | CA2454703C Novel thiophene carboxamide derivatives |
| 01/04/2011 | CA2451241C Unsymmetrical cyclic diamine compound |
| 01/04/2011 | CA2451238C Cyclic diamine compound with 5 membered ring groups |
| 01/04/2011 | CA2429312C Novel pyridine-substituted pyrazolopyridine derivatives |
| 01/04/2011 | CA2427750C Substituted alkanoic acids |
| 01/04/2011 | CA2412941C Piperidine compounds for use as ccr-3 inhibitors |
| 01/04/2011 | CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 01/04/2011 | CA2283754C Use of avian antibodies |
| 01/04/2011 | CA2231916C Erythrocytes loaded with s-nitrosothiol and uses therefor |
| 12/30/2010 | US20100331999 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331420 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331419 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331413 Therapeutic Formulations Based on Asiatic Acid and Selected Salts Thereof |
| 12/30/2010 | US20100331395 Decoy-containing pharmaceutical compositions and method of using the same |
| 12/30/2010 | US20100331386 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
| 12/30/2010 | US20100331375 Biphenyl compounds useful as muscarinic receptor antagonists |
| 12/30/2010 | US20100331342 Immuno Inhibitory Pyrazolone Compounds |
| 12/30/2010 | US20100331337 Quercetin-Containing Compositions |
| 12/30/2010 | US20100331312 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 12/30/2010 | US20100331304 Compounds Which Modulate The CB2 Receptor |
| 12/30/2010 | US20100331302 N-(2-(hetaryl)aryl) arylsulfonamides and n-(2-(hetaryl)hetaryl arylsulfonamides |
| 12/30/2010 | US20100331289 Combination of Azelastine and Steroids |
| 12/30/2010 | US20100331288 Crystalline hydrate of betamimetika and use as medicament thereof |
| 12/30/2010 | US20100331265 Methods for the prevention and treatment of burn injuries and secondary complications |
| 12/30/2010 | US20100331237 Gag binding proteins |
| 12/30/2010 | US20100331236 Cyclic peptides as g-protein coupled receptor antagonists |
| 12/30/2010 | US20100330673 Methods of making enhanced, autologous fat grafts |
| 12/30/2010 | US20100330210 Ghrelin production promoter |
| 12/30/2010 | US20100330207 Methods of treating term and near-term neonates having hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension |
| 12/30/2010 | US20100330205 Pharmaceutical composition |
| 12/30/2010 | US20100330197 Oral or enteral composition useful for recovery of physical functions |
| 12/30/2010 | US20100330188 Carrier particles for use in dry powder inhalers |
| 12/30/2010 | US20100330186 Medicaments for inhalation comprising an anticholinergic and a betamimetic |
| 12/30/2010 | US20100330169 Pharmaceutical Tablet Containing A Liquid Filled Capsule |
| 12/30/2010 | US20100330157 Biomaterial for the controlled delivery of ingredients |
| 12/30/2010 | US20100330150 Orally Disintegrating Tablet Compositions Comprising Combinations of High and Low-Dose Drugs |
| 12/30/2010 | US20100330117 Process for treatment of amyotrophic lateral sclerosis, rheumatoid arthritis, tremors/parkinson's disease, multiple sclerosis, non-viral based cancers, alzheimers's disease, muscular dystrophy, attention deficit disorder, attention deficit hyperactivity disorder, complex regional pain syndrome, diabetes, neuropathic pain, spider arthritis, west nile virus, fibromyalgia, shingles, gout, migraine headaches, senile dementia, post polio syndrome, central virus deafness, asthma, chronic pain of unknown origin and hepatitis c |
| 12/30/2010 | US20100330110 Therapeutic and diagnostic uses of antibody specificity profiles |
| 12/30/2010 | US20100330083 Plasminogen activator variant formulations |
| 12/30/2010 | US20100330077 1-acetic acid-indole derivatives with pgd2 antagonist activity |
| 12/30/2010 | US20100330061 Methods and Devices for Treating Lung Dysfunction |
| 12/30/2010 | US20100330048 Mesenchymal stem cells and uses therefor |
| 12/30/2010 | US20100329998 Novel heterocycles |
| 12/30/2010 | US20100329996 Novel Combination of Therapeutic Agents |
| 12/30/2010 | US20100329984 Respiratory dispersion for metered dose inhalers |
| 12/30/2010 | US20100326437 Inhalable medicament |
| 12/29/2010 | WO2010151784A2 Antimicrobial compounds |
| 12/29/2010 | WO2010150865A1 Crystals |
| 12/29/2010 | WO2010150791A1 Process for production of adenosine tetraphosphate compound |
| 12/29/2010 | WO2010150014A1 5r- 5 -deuterated glitazones for respiratory disease treatment |
| 12/29/2010 | WO2010149634A1 Novel indole, indazole and benzimidazole arylamides as p2x3 and/or p2x2/3 antagonists |
| 12/29/2010 | WO2010149459A1 Use of hat inhibitors and tmprss2 inhibitors as medicaments |
| 12/29/2010 | EP2267032A2 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 12/29/2010 | EP2267027A2 Method of administering therapeutic polypeptides, and polypeptides therefor |
| 12/29/2010 | EP2267026A1 Albumin fusion proteins |
| 12/29/2010 | EP2266626A1 Composition for external application comprising transcription factor decoy as active ingredient |
| 12/29/2010 | EP2266621A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
| 12/29/2010 | EP2266620A2 Pharmaceutical compositions based on anticholinergically effective compounds and beta-mimetics |
| 12/29/2010 | EP2266574A1 Therapeutic use on-demand of formoterol and budesonide |
| 12/29/2010 | EP2266549A2 Method of making particles for use in a pharmaceutical composition |
| 12/29/2010 | EP2265581A1 Compounds having crth2 antagonist activity |